Local Institution - 0028 — Omaha, Nebraska

Local Institution - 0028 is a clinical research site located in Omaha, Nebraska, United States 68198.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Local Institution - 0028 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathy, Systemic Sclerosis.

Sponsors: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 0028?

Local Institution - 0028 has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 0028 conducted?

Local Institution - 0028 has 1 clinical trials on record, with 1 currently active. Their work covers Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathy, Systemic Sclerosis.

Is Local Institution - 0028 accredited by Crixeo Health?

Local Institution - 0028 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 0028?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.